A CHOP allergy specialist recently presented on how to choose the right treatment for eosinophilic esophagitis (EoE) at the EAACI Annual Congress 2020. The international conference for health professionals was held digitally this year on June 6-8 due to the COVID-19 pandemic.
Antonella Ciaferoni, MD, PhD , an attending physician in the Division of Allergy and Immunology, the Center for Pediatric Eosinophilic Disorders and the Food Allergy Center at Children's Hospital of Philadelphia (CHOP), presented "Which Treatment to Choose for Eosinophilic Esophagitis: Understanding Eosinophilic Esophagitis Molecular Mechanisms to Decide How to Treat Your Patients."
Dr. Cianferoni's presentation was part of Symposium 33: Towards personalized medicine in atopic barrier disorders, along with Kormel Golebski, PhD, from the Netherlands, and Susan Chan from the United Kingdom.
Seminar goals included:
- Providing novel insights into targeting innate immune components in allergic rhinitis and nasal polyps,
- Providing novel insights into the management of diseases with dysfunctional epithelial barrier (such as EoE), and
- Discussing the use of biologicals to restore the epithelial barrier.
To learn more about the EAACI's annual conference, visit www.eaaci.org.